Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Bristol-Myers Squibb — Celgene
Entity

Bristol-Myers Squibb — Celgene

Tracked across 1 events · 6 articles · First seen May 01, 2026 · Last active May 01, 2026

Sentiment
70
Attention
8
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
8 70
Business
Biotech M&A Surges Amid Patent Cliffs
The biotech sector is experiencing a significant surge in mergers and acquisitions (M&A) in 2026, with deal values already reaching $84 billion in the first quarter, making it the strongest start since 2019. This accelerated…
Impact: Bristol-Myers Squibb — Celgene was acquired by Bristol Myers Squibb in a mega-merger that significantly contributed to the high M&A value in 2019, serving as a benchmark for the current dealmaking pace.
May 01, 2026 · 6 articles
Key Actions (1)
60 Bristol Myers Squibb purchased Bristol-Myers Squibb — CelgeneBiotech M&A Surges Amid...
NEWSDESK
Track Bristol-Myers Squibb — Celgene live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.